2023 annual financial data

Milestone Pharmaceuticals 2023 Financial results

Direct answer

Revenue was 1,000,000 USD.

Operating income was -61,098,000 USD and net income was -59,685,000 USD.
Operating cash flow was -46,424,000 USD.

Get free Milestone Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,000,000 USD
Operating income
-61,098,000 USD
Net income
-59,685,000 USD
Operating cash flow
-46,424,000 USD